Literature DB >> 8137833

Borderzone infarct subtypes: preliminary study of the presumed mechanism.

F Mounier-Vehier1, D Leys, O Godefroy, P Rondepierre, M Marchau, J P Pruvo.   

Abstract

Whether watershed infarcts and internal junctional infarcts have different mechanisms remains unknown. Of 493 consecutive patients with ischemic stroke or transient ischemic attack, 26 had 1 watershed infarct or more (8 anterior and 21 posterior) and 18 had 1 internal junctional infarct or more. Patients with watershed infarcts were more likely to have arterial hypertension [95% confidence intervals of odds ratio (CIOR): 1.04-6.15] and internal carotid artery stenosis > 50% (95% CIOR: 1.03-7.12) than patients without borderzone infarcts. Patients with internal junctional infarcts were more likely to have heart diseases than patients without borderzone infarcts (95% CIOR: 1.46-10.52). This preliminary study suggests that both subtypes of borderzone infarcts probably have different mechanisms.

Entities:  

Mesh:

Year:  1994        PMID: 8137833     DOI: 10.1159/000117001

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

1.  Small subcortical infarcts and primary subcortical haemorrhages may have different risk factors.

Authors:  E Janssens; F Mounier-Vehier; M Hamon; D Leys
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

2.  Cerebellar border zone infarcts are often associated with presumed cardiac sources of ischaemic stroke.

Authors:  F Mounier-Vehier; I Degaey; X Leclerc; D Leys
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

3.  Dynamics of brain perfusion and cognitive performance in revascularization of carotid artery stenosis.

Authors:  Julian Schröder; Marlene Heinze; Matthias Günther; Bastian Cheng; Alina Nickel; Tanja Schröder; Felix Fischer; Simon S Kessner; Tim Magnus; Jens Fiehler; Axel Larena-Avellaneda; Christian Gerloff; Götz Thomalla
Journal:  Neuroimage Clin       Date:  2019-03-13       Impact factor: 4.881

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.